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Pluripotency is the remarkable capacity of a single cell to engender all the specialized cell types of an adult
organism. This property can be captured indefinitely through derivation of self-renewing embryonic stem
cells (ESCs), which represent an invaluable platform to investigate cell fate decisions and disease. Recent
advances have revealed that manipulation of distinct signaling cues can render ESCs in a uniform ‘‘ground
state’’ of pluripotency, which more closely recapitulates the pluripotent naive epiblast. Here we discuss
the extrinsic and intrinsic regulatory principles that underpin the nature of pluripotency and consider the
emerging spectrum of pluripotent states.Introduction
The pluripotent state is the fundamental building block at the root
of embryonic development. Cells that acquire pluripotency harbor
the functional capacity to give rise to all the somatic lineages of
the embryo and to the germline. In vivo, the pluripotent state
emerges during development of a totipotent zygote toward a
blastocyst. This process delineates two lineages: the inner cell
mass (ICM), which is the pluripotent founder population, and the
trophectoderm (TE), which forms an extraembryonic epithelial
layer that envelopes and supports the ICM. At the late blastocyst
stage (embryonic day 4.0 [E4.0]) the ICMconsolidates to establish
the pluripotent Nanog-expressing epiblast lineage and an over-
lying extraembryonic layer of Gata6-expressing primitive endo-
derm (also known as hypoblast) (Silva et al., 2009). At this point
the partitioned epiblast cells enter the developmental ‘‘ground
state,’’ the origin of all future embryonic lineages (Figure 1).
Acquisition of the ground state in the epiblast is characterized
by uniform expression of key pluripotency factors and reactiva-
tion of the paternal X chromosome in female embryos. This is
paralleled by the establishment of a derestricted epigenome,
including global DNA hypomethylation. The ground state can
therefore be considered a cellular condition that is liberated
from epigenetic and developmental constraints, a so-called
blank slate (Silva and Smith, 2008). Functionally, ground state
epiblast cells are described as being in a ‘‘naive’’ state of plurip-
otency, which reflects their unbiased developmental potential.
As postimplantation development proceeds however (from
E5.0), powerful inductive stimuli trigger naive epiblast cells to
transit to a ‘‘primed’’ phase of pluripotency that is poised to
initiate lineage-specification programs and is epigenetically
restricted (Nichols and Smith, 2009). Naive pluripotency in the
embryo is, consequently, an inherently transient condition.
Nevertheless, the ephemeral nature of naive pluripotency can
be captured indefinitely in vitro, through derivation of embryonic
stem cells (ESCs) from the ICM or through experimental reprog-
ramming strategies (Evans and Kaufman, 1981; Martin, 1981;
Yamanaka andBlau, 2010). Under permissive culture conditions,416 Cell Stem Cell 15, October 2, 2014 ª2014 Elsevier Inc.ESCs retain naive pluripotent capacity while undergoing self-
renewal—cell division without loss of cellular identity—and
thus represent a surrogate model of the naive epiblast that is
effectively kept in stasis.
Remarkably, when reintroduced back into the early embryo,
ESCs that have undergone extensive in vitro expansion are
induced to exit self-renewal and can efficiently contribute to all as-
pects of embryonic development (Bradley et al., 1984). If intro-
duced into a tetraploid donor blastocyst, which cannot complete
fetal development, healthy adult mice can be derived that are
exclusively composedofhitherto invitroculturedESCs, stringently
underscoring their unrestricted potency (Nagy et al., 1993). Impor-
tantly, thisoccurswithout tumorigenesis, demonstrating that in the
appropriate context, ESCs retain full control over the develop-
mental program. Because ESCs can efficiently colonize the germ-
line, they represent a highly tractable system for constructing
genetically engineered lines of mice such as gene knockouts.
Additionally, the unique properties of ESCs make them an in-
valuable tool for modeling developmental processes and disease.
More recently, a model of the primed pluripotent state termed
epiblast stemcells (EpiSCs)havealsobeenderived,whichprovide
a complementary system to investigate pluripotency and cell fate
decisions (Brons et al., 2007; Tesar et al., 2007).
In this Review, we discuss the fundamental principles that
underpin the self-renewing pluripotent state(s). We consider
the emerging spectrum of pluripotency that ranges from the
naive ‘‘ground state’’ to the developmentally ‘‘primed’’ state.
In particular, we focus on the accumulating knowledge of the
functional, epigenetic, and signaling properties that contribute
to propagating ground state pluripotency in murine ESCs.
The progress in this field has paved the way for defining and
establishing naive human ESCs (hESCs) and we consider these
recent advances.
Propagating Naive Pluripotency
Classically, mouse ESCs are derived through explanting an
intact blastocyst or an isolated ICM onto a layer of mitotically
Figure 1. Establishment of the Pluripotent
Ground State In Vivo
Development of the zygote proceeds through
cleavage divisions to form a morula, which elabo-
rates the extraembryonic trophectoderm (TE)
lineage and the pluripotent inner cell mass (ICM) of
the blastocyst at E3.5. The ICM expresses both
Gata6 (green) and Nanog (blue) but subsequently
segregates into the extraembryonic primitive
endoderm (PrE) and pluripotent naive epiblast
(EPI), which exhibit mutually exclusive expression
of these genes, respectively. The EPI is the source
of all embryonic lineages, including the germline,
and is therefore the developmental ‘‘ground state.’’
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endow trophic factors that together with fetal calf serum
engender a complex culture medium that supports self-renewal.
ESC culture media is typically supplemented with the signaling
molecule leukemia inhibitory factor (LIF), which can substitute
for feeders in the presence of an appropriate extracellular matrix
such as gelatin (Smith et al., 1988; Williams et al., 1988). Under
serum/LIF conditions (+/ feeders) ESCs are denoted as ‘‘con-
ventional’’ or ‘‘serum’’ ESCs. These cells have a high nuclear/
cytoplasmic ratio, form domed colonies of tightly packed but
heterogeneous cells, and are competent to be passaged as col-
ony forming single cells, a property referred to as clonogenicity.
A hallmark of such ESCs is the expression of Oct4, Sox2, and to
some extent Nanog, which together with a suite of intercon-
nected regulators, underpin pluripotency (Young, 2011; Dunn
et al., 2014). Historically it has only been possible to efficiently
derive ESCs from the 129 strain of mice using serum/LIF condi-
tions, implying that competence for self-renewal is significantly
influenced by genetic background (Gardner and Brook, 1997).
The derivation of ESCs from the ICM in serum is linked with
ongoing transcriptional changes and it has been suggested
that such derivation may occur via a primordial germ cell
(PGC)-like program (Chu et al., 2011; Tang et al., 2010). How-
ever, loss of the obligatory PGC factor Blimp1 does not impede
ESC derivation, confirming that ESCs represent direct capture
of the naive epiblast state (Bao et al., 2012). Nevertheless, one
consequence of the derivation and maintenance of ESCs in
serum is that undefined and often conflicting signaling pathways
are activated. While such conditions sustain naive pluripotency
at the level of the cellular population, they also promote a signif-
icant degree of morphological, transcriptional, and ultimately
functional heterogeneity among cells (Chambers et al., 2007;
Hayashi et al., 2008; Toyooka et al., 2008). As a result conven-
tional ESCs exist in at least two distinct populations that broadly
correspond to a naive state, which is functionally comparable
to the preimplantation epiblast, or the more developmentally
advanced ‘‘primed’’ state linked with expression of lineage-
associated genes and poor performance in pluripotency assays.
These subpopulations do however interchange their identity in
culture (Abranches et al., 2013), suggesting that the transcrip-
tional and functional differences between states are in dynamic
equilibrium, at least to some extent, and thus that ESCs in serum
can be considered ‘‘metastable,’’ cycling in and out of naive sta-
tus. Further subpopulations may also persist in serum that, for
example, are primed toward extraembryonic primitive endoderm
fate or have irretrievably exited a pluripotent state, highlighting
overall population heterogeneity (Canham et al., 2010).The accumulated knowledge of the molecular circuitry that
underpins pluripotency has recently led to the development of
novel conditions that preferentially stabilize the naive state in cul-
ture. Principally, the use of two small-molecule kinase inhibitors,
termed ‘‘2i,’’ harnesses ESCs in a distinct transcriptional and
epigenetic state that includes uniform expression of key pluripo-
tency factors, such as Nanog and Prdm14, and global DNA
hypomethylation (Leitch et al., 2013; Yamaji et al., 2013; Ying
et al., 2008). This is paralleled by a consistent relatively spherical
colonymorphology, with defined borders that lack differentiating
cells, and enhanced clonogenicity. The 2i components comprise
a specific inhibitor of the FGF/ERK signal transduction pathway,
known as PD03 (PD0325901) and a specific inhibitor of GSK3,
referred to as CHIRON (CHIR99021), that collectively shield
ESCs from inductive differentiation stimuli (discussed below)
and select against differentiating cells (Ying et al., 2008). Impor-
tantly, ESCs maintained in 2i are consistently competent to
form high-contribution mouse chimeras with germline transmis-
sion—often with notably greater efficiency than ESCs from
serum conditions—and thus robustly satisfy the defining test of
naive pluripotency.
Culture using the 2i system is typically carried out in both a
feeder- and serum-free growth medium, such as N2B27, with
optional addition of LIF. Standard 2i conditions are therefore
highly chemically defined and thus theoretically more reproduc-
ible than serum-based culture. The use of the 2i culture system
also bears the significant advantage that it facilitates derivation
of pluripotent ESCs from all tested strains of mice, including bio-
logically important but previously recalcitrant strains, such as
nonobese diabetic (NOD) and FVB (Kanda et al., 2012; Nichols
et al., 2009; ten Berge et al., 2011). Indeed, pluripotent stem cells
can also be established from other developmental sources using
2i, such as rat preimplantation epiblast or PGCs, that adopt
almost identical properties to mouse ESCs, suggesting that
2i promotes a generic naive state, at least in rodents (Buehr
et al., 2008; Leitch et al., 2010). It remains to be determined how-
ever whether ESCs maintained in 2i over an extended culture
period are karyotypically and epigenetically stable (at genomic
imprints for example), an important feature of ESCs propagated
in serum/LIF.
Defining the Ground State In Vitro
The ‘‘ground state’’ is considered here as the unrestricted naive
pluripotent state established in vivo in the epiblast cells of the
mature blastocyst (Figure 1). This differs subtly from ‘‘naive
pluripotency’’ per se, which is strictly a functional property attrib-
uted to any cell that exhibits the unbiased capacity to give riseCell Stem Cell 15, October 2, 2014 ª2014 Elsevier Inc. 417
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tive of how closely or not it mirrors the developmental ground
state established in vivo. Both serum/LIF and 2i/LIF culture con-
ditions are conducive for maintenance of naive pluripotency, as
judged by chimera contribution. However, most ESCs in serum/
LIF exhibit an altered transcriptional and epigenetic profile rela-
tive to preimplantation epiblast cells and thus, at the population
level, are considered to be functionally naive but not ground
state.
In contrast, the molecular and functional properties of ESCs in
2i/LIF are consistent with most of these cells being in an opti-
mized state of naive pluripotency that is closely comparable
to the developmental ground state in vivo. For example,
ESCs in 2i exhibit significantly reduced/absent expression of
lineage-associated genes, a permissive epigenetic landscape,
and cluster closely with E4.5 epiblast cells at the single-cell
transcriptome level (Boroviak et al., 2014; Marks et al., 2012).
For this reason ESCs in 2i (+/LIF) are referred to as being
‘‘ground state,’’ since they are both functionally naive and a
close molecular approximation of the epiblast cells of the blas-
tocyst. It is important to consider however that while the 2i
system represents the best available approach to model the
developmental ground state, it remains an inherently imperfect
recreation, at least because self-renewal is not part of the in vivo
program. Thus, in the context of pluripotent cells in vitro, the
ground state can be considered to be the most pristine or opti-
mized state of naive pluripotency on a spectrum of multiple
naive states.
Extrinsic Signaling Pathways for Naive Pluripotency
The capacity for ESCs to indefinitely retain naive pluripotency in
culture requires a continuous input from extrinsic signals. Such
exogenous cues are requisite owing to ESC-derived autocrine
factors that promote exit from the self-renewal program and in
particular fibroblast growth factor (FGF). Secretion of FGF4 in
culture feeds back through the MEK/ERK signaling cascade to
sensitize ESCs to instructive differentiation signals, which in
turn direct commitment to specific lineages (Kunath et al.,
2007; Stavridis et al., 2007). Because Fgf4 expression in ESCs
is activated by OCT4 and SOX2, its prodifferentiation influence
is directly wired into the core pluripotency circuitry (Yuan et al.,
1995). Other influences intrinsic to ESCs, such as the NuRD
corepressor complex, also antagonize maintenance of naive
status (Reynolds et al., 2012). Thus, without culture conditions
that counterbalance or inhibit inductive differentiation signals
emanating from ESCs themselves, self-renewal is inherently de-
stabilized. As such, modulation of key extrinsic pathways such
as JAK/STAT3 activation, WNT signaling, BMP4 activity, or
FGF is important to maintain ESC identity and is considered
here in the context of the principal culture conditions serum/
LIF and 2i.
Serum/LIF Culture
The conventional regime of serum-supplemented culture influ-
ences multiple signaling pathways. However, an essential factor
is LIF, which acts via binding the gp130/LIF-R cell-surface re-
ceptor complex (Yoshida et al., 1994). Downstream, JAK kinases
phosphorylate and activate the transcription factor STAT3,
which is the critical effector of LIF. Consistently, the absence
of Stat3 is incompatible with ESC self-renewal in serum/LIF,418 Cell Stem Cell 15, October 2, 2014 ª2014 Elsevier Inc.whereas its overexpression is sufficient to drive LIF-independent
self-renewal (Niwa, 2007). The key role of STAT3 is further re-
vealed by its requirement to sustain the pluripotent ICM in vivo
(Do et al., 2013).
Mechanistically, phosphorylated STAT3 translocates to the
nucleus in ESCs, where it regulates several pluripotency-pro-
moting targets including Klf4, Gbx2, and possibly c-Myc (Cart-
wright et al., 2005; Hall et al., 2009; Niwa et al., 2009; Tai and
Ying, 2013). Because forced expression of these targets does
not fully recapitulate STAT3 activity however, LIF is expected
to modulate further genes. Indeed, elegant recent studies have
demonstrated that the transcription factor Tfcp2l1 is likely the
primary target promoting pluripotency downstream of LIF/
STAT3 (Martello et al., 2013; Ye et al., 2013). As such, Tfcp2l1
is necessary for ESC responsiveness to LIF in conventional con-
ditions and, conversely, forced Tfcp2l1 expression is sufficient to
support self-renewal in the absence of LIF. However, LIF does
additionally activate the PI3K/AKT and MEK/ERK signal cas-
cades, as well as bona fide STAT3 target Klf4, implying that while
Tfcp2l1 is the critical mediator, the full activity of LIF may be
realized through integrating multiple direct targets (Figure 2)
(Niwa et al., 2009). Paradoxically, this includes weak stimulation
of the differentiation-inducing MEK/ERK pathway.
In conjunction with LIF, fetal calf serum sustains self-renewal
in conventional conditions. The crucial component of serum is
BMP4, which acts via downstream SMAD signaling pathways
to activate Inhibitor of Differentiation (Id) genes. Forced expres-
sion of Id genes or addition of exogenous BMP4 to culture sub-
stitutes for serum to maintain self-renewal. This regulation may
function in part by promoting expression of E-Cadherin, which
restrains cell fate commitment (Malaguti et al., 2013). In the
absence of BMP4, ESCs progressively differentiate toward neu-
roectoderm derivatives, whereas absence of LIF from culture re-
sults in extensive nonneural differentiation (Ying et al., 2003). The
prevalence of reciprocal differentiation pathways when either
component is removed has fostered the assumption that LIF
and BMP4 together support self-renewal by each suppressing
differentiation toward specific fates, collectively restricting ac-
cess to all lineages.
2i Culture
Culture in serum/LIF sustains self-renewal by overriding or coun-
teracting differentiation stimuli downstream of their effects and,
thus, ESCs in conventional conditions exist in a battleground
of competing signals that precipitates in metastability. It is desir-
able therefore to identify conditions that insulate from, rather
than counteract, differentiation-inducing signals, thereby stabi-
lizing the upstream naive state. The key candidate formodulation
is the FGF-ERK pathway. Fgf4/ ESCs are severely compro-
mised in differentiation toward both neural and mesendoderm
lineages, implying FGF4 is upstream of cell fate commitment.
A comparable phenotype is observed in Erk2/ ESCs, high-
lighting ERK1/2 as the downstream effector of FGF4 (Kunath
et al., 2007; Stavridis et al., 2007). The FGF/ERK pathway thus
appears to drive transition out of naive status to a primed state
that is susceptible to further lineage-specifying cues. Mechanis-
tically, activated ERK2 phosphorylates the pluripotency protein
KLF2 leading to its proteosomal degradation and, consequently,
acts to destabilize the naive network (Yeo et al., 2014). In parallel,
ERK1/2 directly promotes competence for the primed state by
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Figure 2. Extrinsic Signaling Pathways that Feed into Reinforcing or Antagonizing Naive Pluripotency
Simplified schematic of various signaling cascades that affect self-renewal. Filled arrows indicate activation, whereas bars show inhibition or blockade of
target activity. A solid line implies a direct or known downstream target and a dashed line indicates an indirect or inferred effect. Clockwise: BMP4 is
present in serum and functions via SMADs to activate Id genes. LIF signaling affects many pathways but primarily acts via JAK-mediated phosphorylation
of STAT3, which activates Tcfp2l1 and Klf4. Canonical WNT signaling blocks GSK3 activity leading to stabilization of b-catenin, which in turn abrogates
TCF3-mediated repression of pluripotency genes including Esrrb. CHIRON closely mimics WNT signaling by inhibiting GSK3. FGF signaling activates the
MAPK pathway leading to phosphorylation of MEK, which in turn phosphorylates and activates ERK. Activated ERK promotes transition to ‘‘a primed’’
state, which is therefore blocked by the MEK inhibitor PD03.
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2014).
It was therefore hypothesized that blockade of ERK activity
would robustly capture the upstream naive state (Silva and
Smith, 2008). Indeed, the potent MEK inhibitor PD03, which
blocks phosphorylation and hence activation of ERK1/2, pro-
motes long-term self-renewal and colony formation in defined
media (Figure 2) (Ying et al., 2008). However, while inhibition of
ERK suppresses differentiation, PD03 is insufficient to support
ESC viability in the absence of LIF. Based on knowledge that
inhibition of another kinase, GSK3, enhanced ESC self-renewal
(Ogawa et al., 2006; Sato et al., 2004), it was found that addi-
tion of the GSK3 inhibitor CHIRON to PD03 culture stabilizes
ESC propagation, even without LIF or BMP4/serum. This rescue
of ESCs is closely phenocopied in Gsk3a/Gsk3b-null ESCs,
demonstrating that GSK3 is the specific target of CHIRON
(Ying et al., 2008). Collectively PD03 and CHIRON comprise
the ‘‘2i’’ culture system.
The effects of GSK3 inhibition on self-renewal are principally
mediated through stabilizing b-catenin. Indeed, ESCs lacking B-
catenin do not respond to CHIRON, confirming a direct effect
(Lyashenko et al., 2011; Wray et al., 2011). Such stabilization
of b-catenin effectively mimics stimulation of canonical WNT
signaling, which is thought to restrict progression from naive to
primed status (ten Berge et al., 2011; Yi et al., 2011). Mechanisti-
cally, stabilized b-catenin translocates to the nucleus, where it
may enhance expression of pluripotency factors through interac-
tions with OCT4 or via weakly expressed TCF1 (Kelly et al., 2011;
Yi et al., 2011). However, it appears that the primary role of nuclearb-catenin in self-renewal arises through interactionswith its defin-
itive partner and transcriptional repressor TCF3. In ESCs, TCF3 is
colocalized with OCT4 and SOX2 at core pluripotency genes,
where the repressor activity of TCF3 competes to antagonize
OCT4/SOX2 activity. However, the interaction between TCF3
and b-catenin disrupts TCF3-mediated repression of these tar-
gets, thus stabilizing the naive self-renewal program (Faunes
et al., 2013; Wray et al., 2011). Inhibition of GSK3 with CHIRON
therefore relieves suppression of pluripotency genes by TCF3
and, consistently, genetic studies reveal Tcf3 null ESCs exhibit
enhanced self-renewal (Guo et al., 2011; Yi et al., 2011).
The critical target antagonized by TCF3 is Esrrb, since forced
expression of Esrrb substitutes for GSK3 inhibition to restore
viability, whereas ablation of Esrrb largely eliminates the self-
renewal response to 2i conditions (Martello et al., 2012). GSK3
inhibition with CHIRON therefore effectively represents an
extrinsic stimulus that operates through WNT signaling to rein-
force the pluripotency gene network (Loh and Lim, 2011). This
suggests that the ground state is not an inherently stable condi-
tion that can only be perturbed by differentiation cues but instead
requires continuous extrinsic input. Thus, 2i conditions elicit the
in vitro ground state through both shielding ESCs from differen-
tiation stimuli and also via engaging with the core pluripotency
circuit to reinforce its expression. The 2i system additionally ap-
pears to be inherently selective against cells that have exited
naive status (most cell types, including primed cells, differentiate
or die in 2i), and indeed this property can be exploited to select
for transition from partially reprogrammed pre-iPS to naive
induced pluripotent stem cells (iPSCs) (Silva et al., 2008).Cell Stem Cell 15, October 2, 2014 ª2014 Elsevier Inc. 419
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An emerging theme is that naive pluripotency can be maintained
by modulating several independent extrinsic signaling pathways
(Figure 2). Moreover, because these various pathways signal
through parallel routes, they act additively to reinforce pluripo-
tency. Indeed, the optimal culture condition for robust self-
renewal of ground state ESCs comprises the three additive 2i/
LIF supplements (CHIRON, PD03, LIF), which primarily affect ca-
nonical WNT, FGF/ERK, and JAK/STAT signals. Notably, how-
ever, any combination of two of these tripartite supplements is
sufficient tomaintain naive self-renewal, at least in tested genetic
backgrounds (Wray et al., 2010; Dunn et al., 2014). The extrinsic
pathways impinged on by PD03, CHIRON, and LIF are therefore
to some extent redundant and can compensate for the absence
of one another to engender a naive state. Indeed the combina-
tion of FGF/ERK inhibition and BMP4 pathway augmentation
also elicits an apparent self-renewing ground state (Hassani
et al., 2014).While each extrinsic regulator has unique critical tar-
gets, there is also a degree of crosstalk and overlap as CHIRON,
LIF, and even PD03 all converge on activation of Tfcp2l1 (Ye
et al., 2013).
The redundancy between extrinsic inputs for self-renewal is
evidenced by deletion of the critical LIF effector Stat3 or its key
target Tfcp2l1. This loss renders ESCs nonviable in serum/LIF
conditions, yet is inconsequential for self-renewal in 2i because
essential LIF/STAT3 functions are compensated for by activation
of canonical WNT signaling and blockade of FGF/ERK (Martello
et al., 2013; Ying et al., 2008). Conversely, the CHIRON effector
b-catenin and downstream target Esrrb are absolutely required
for efficient self-renewal in 2i but are dispensable in serum con-
ditions, where LIF/STAT3 and BMP4 activity can bypass their
function to sustain ESC identity (Martello et al., 2012; Wray
et al., 2011). The same is true for Klf2, which appears to be an
essential component of the pluripotency circuit in 2i but not
serum (Yeo et al., 2014). Notably, however, the tripartite 2i/LIF
condition robustly maintains a naive state when any of these
genes is absent, underscoring the redundancy generated by
multiple pro-self-renewal pathways.
Thus, naive pluripotency, and indeed an unrestricted ‘‘ground
state,’’ can apparently be elicited through independent inputs
that operate through both unique and convergent targets, with
ESCs able to well-tolerate removal of one (or more) input as
long as others are in play. Above a threshold level of extrinsic
influences that either block differentiation or activate naive
genes, pluripotency is robustly stabilized. Notably, the theoret-
ical threshold level to stabilize naive status may vary in different
genetic backgrounds, where the sensitivity to specific pathways
is altered. For example, non-129 ESCs may exhibit enhanced
susceptibility to prodifferentiation FGF/ERK signaling, as may
XY as opposed to XX ESCs, implying a heightened dependence
on blockade of this stimulus to maintain naive status (Hanna
et al., 2009; Schulz et al., 2014). Moreover, other influences
intrinsic to ESCs can encourage exit from self-renewal, such
as the translational regulator PUM1, the zinc-finger protein
ZFP706, the subcellular localization of the transcription factor
TFE1, and the NURD corepressor complex, and may need to
be overcome to differing extents in different genetic contexts
(Betschinger et al., 2013; Leeb et al., 2014; Reynolds et al.,
2012). It will be of interest to elucidate the context-dependent420 Cell Stem Cell 15, October 2, 2014 ª2014 Elsevier Inc.molecular signatures generated by combinations of culture sup-
plements to dissect precisely how various extrinsic pathways
impinge on the ‘‘state’’ of pluripotency.
Intrinsic Networks for Naive Pluripotency
Downstream of extrinsic signals, regulatory networks of tran-
scription factors (TFs) and cofactors propagate the gene expres-
sion programs that underpin naive pluripotency (Young, 2011).
Such intrinsic genetic networks have been extensively interro-
gated and two TFs, Oct4 and Sox2, emerge as the fundamental
lynchpins. These factors are required for both the acquisition and
maintenance of pluripotency, and Oct4 and Sox2 are therefore
defined here as ‘‘core’’ pluripotency factors, albeit the critical
role of Sox2 may be to activate Oct4 (Avilion et al., 2003; Masui
et al., 2007; Nichols et al., 1998). Both Oct4 and Sox2 are ex-
pressed continually and relatively uniformly in ESCs under all
standard conditions. In the acute absence of Oct4 or Sox2,
ESCs progressively differentiate toward trophectoderm deriva-
tives, while overexpression also elicits lineage specification,
implying that precisely regulated OCT4 and SOX2 levels are
crucial for the balance between self-renewal and differentiation
(Masui et al., 2007; Niwa et al., 2000; Thomson et al., 2011).
Indeed, limiting the range of Oct4 expression to only intermedi-
ate levels by using heterozygous ESCs actually stabilizes a uni-
form naive state (Karwacki-Neisius et al., 2013).
In addition toOct4 andSox2,Nanog is historically included asa
key TF as it is crucial for the acquisition, but not maintenance, of
naive pluripotency (Chambers et al., 2007; Silva et al., 2009). The
requirement for Nanog to acquire naive pluripotency in vitro can
however be bypassed, implying thatNanog plays a distinct func-
tional role fromOct4 andSox2 (Carter et al., 2014; Schwarz et al.,
2014). Nonetheless, the Oct4/Sox2/Nanog (OSN) triumvirate
acts cooperatively in ESCs to bind overlapping genomic targets,
including their own promoters, and thus forms a robust auto-
regulatory network that self-maintains pluripotency. Prominent
among OSN targets are cis-acting regulatory elements, where
OSN acts both directly and as a platform to recruit diverse
coactivators and TFs that collectively execute the pluripotency
expression program. Importantly, OSN occupancy correlates
with cobinding by STAT3, b-catenin, and SMAD1, which are the
effectors of the propluripotency signaling cascades activated
by LIF, WNT, and BMP4, respectively, thus directly coupling
these signaling pathways to the genes regulated by the core plu-
ripotency circuitry (Chen et al., 2008; Loh et al., 2006; Young,
2011). The repressor TCF3 also engages with OSN to antagonize
activation of its targets (Cole et al., 2008), and thus CHIRON-
mediated abrogation of TCF3 activity via stabilized b-catenin
enhances self-renewal. Notably, when signaling cues are
switched to primed FGF/Activin conditions, OCT4 redistributes
away from naive genes to occupy enhancers associated with
early development through interactions with OTX2, underscoring
howcoreTFscan integrate extrinsic cues in acontext-dependent
manner (Buecker et al., 2014; Factor et al., 2014).
ESCs also express a repertoire of ‘‘ancillary’’ pluripotency
regulators such as Klf2, Esrrb, Klf4, Prdm14, Sall4, Tfcp2l1,
and Tbx3 that reinforce and buffer the pluripotency network
against prodifferentiation influences but are typically individually
dispensable for pluripotent identity. Indeed, the expendable role
ofNanog for pluripotencymeans it is also included as an ancillary
Figure 3. Genetic Networks for
Maintenance of Naive Pluripotency
The pluripotency network includes essential core
components (Oct4/Sox2) and multiple ancillary
factors (shown in green) that collectively form a
self-organizing circuitry. Ancillary factors generally
act to buffer the network against fluctuations and
perturbations that promote exit from self-renewal
(shown in red). In serum (left), ancillary factors are
heterogeneous among the population and thus
render individual ESCs in varying states of sus-
ceptibility to inherent influences that promote exit
from self-renewal such as the FGF/ERK pathway
or NuRD corepressor complex activity (shown as
canals in the ancillary bubble). When the pluripo-
tency network is stabilized through blocking key differentiation influences and/or by directly reinforcing expression of ancillary factors (e.g., 2i/LIF, right), the
influences that drive exit from self-renewal are mitigated and robust naive pluripotency emerges.
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sion through feedback loops, at least indirectly, and thus form a
redundant self-organizing circuit (Dunn et al., 2014). In conven-
tional conditions, many ancillary factors exhibit heterogeneous
expression, fluctuating between on and off states at the single-
cell level and thus render individual ESCs in varying degrees of
susceptibility to distinct lineage-specifying cues (Figure 3)
(Chambers et al., 2007; Martello et al., 2012; Toyooka et al.,
2008; Yamaji et al., 2013). In 2i however these factors appear
to be homogenously expressed among the population, which
may both reflect and contribute to stabilized naive pluripotency
(Wray et al., 2010).
When active, ancillary factors can act through both over-
lapping and distinct mechanisms to affect pluripotency. For
example, SALL4 associates with OCT4 to promote repression
of trophectoderm genes and stabilizes expression of Oct4 itself
(Zhang et al., 2006). ESSRB on the other hand directly integrates
into the pluripotency TF circuitry by fine-tuning the expression
level of key targets cooperatively with NANOG, while PRDM14
represses FGF signaling and DNA methylation (Festuccia et al.,
2012; Grabole et al., 2013; Yamaji et al., 2013). In serum condi-
tions, other groups of collaborative TFs or ‘‘modules’’ are also
considered important. The ‘‘Myc’’ module, for example,
promotes rapid transition through G1 cell cycle and suppresses
differentiation, in part by activating Dusp2 and Dusp7 phospha-
tases that repress FGF/ERK (Cartwright et al., 2005; Chappell
et al., 2013). These modules and the extended genetic networks
that underpin pluripotency in serum have been extensively re-
viewed (Chambers and Tomlinson, 2009; Jaenisch and Young,
2008; Loh et al., 2011; Ng and Surani, 2011; Young, 2011).
The current knowledge of the molecular determinants of plu-
ripotency is largely inferred from conventional ESC conditions.
This is an important consideration because such serum condi-
tions sustain self-renewal through distinct pathways, and hence
through at least subtly altered networks, to ground state ESCs.
Thus, while the genetic networks in serum conditions represent
one route to engender functional pluripotency, they by nomeans
represent the only or defining molecular signature of self-renew-
ing naive pluripotency per se. For example, the Myc module,
which is critical in serum, is almost entirely silenced in 2i.
Indeed, approximately 25% of active ESC genes are differen-
tially expressed between 2i/LIF and serum/LIF conditions
(3,500 genes, >2-fold) (Marks et al., 2012). Functional pluripo-
tency is therefore apparently maintained across a surprisinglywide bandwidth of transcriptional (and epigenetic) variation.
Consequently, while important work has elucidated a persuasive
model to describe pluripotency in the context of conventional
ESCs, the extent to which existing paradigms are absolute
requirements or context-dependent nodes for eliciting naive plu-
ripotency is unclear.
This ambiguity is exemplified by Prdm14, which has been
shown to be a critical component of the genetic framework
that supports ESC self-renewal in serum, thus implying an
essential function in pluripotent identity in general. However,
Prdm14 is dispensable for both the self-renewal of ESCs in 2i
and for executing all differentiation pathways, highlighting a
strictly context-dependent role (Grabole et al., 2013; Yamaji
et al., 2013). Such ambiguities are also probably relevant, at least
to some extent, for the precise roles of other TFs, small RNAs,
epigenetic mechanisms, and cis-regulatory elements that input
into pluripotency. Understanding how various regulatory com-
ponents integrate into pluripotency in distinct contexts and their
interplay will be an important aspect of future studies.
Insights into the transcriptional foundations of conventional
and ground state ESCs have however recently been established,
with several conclusions deducible (Dunn et al., 2014; Marks
et al., 2012). For example, cell-cycle genes are downregulated
in 2i/LIF, whereasmetabolic genes are highly upregulated, which
may be related to parallels between ground state ESCs and early
development where shifts in metabolic pathways occur (Zhou
et al., 2012). Alternatively, the high metabolic activity in 2i
conditions could be indicative of increased cellular stress. We
consider here significant distinctions and overlaps between con-
ventional serum/LIF ESCs and ground state ESCs in 2i/LIF.
Pluripotency Gene Networks
First, Oct4 and Sox2 are expressed at comparable levels be-
tween serum and 2i/LIF, suggesting that at the population level,
there is no inherent difference in the core circuitry between
states. Most ancillary pluripotency genes, including Tbx3, Esrrb,
Nanog, Klf4, and Klf2, are however expressed moderately higher
in 2i/LIF conditions (typically <2-fold up). This primarily reflects a
switch from mosaic expression in serum to expression by all
cells in 2i/LIF, since differences are mitigated by comparing
the naive Rex1-positive population from serum to ground state
ESCs (Marks et al., 2012). Some pluripotency factors/markers,
including Prdm14, Stella, Tcl1, and Tfcp2l1, are nevertheless
directly upregulated in 2i/LIF (typically 2- to 5-fold up), which
may be a consequence of stabilizing the naive circuitry orCell Stem Cell 15, October 2, 2014 ª2014 Elsevier Inc. 421
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for reinforcing the ground state downstream of 2i signaling.
Consistent with the latter, forced expression ofPrdm14 can drive
a homogenous Rex1-positive state, even in conventional condi-
tions, while Tcfp2l1 overexpression efficiently reprograms
primed EpiSCs to naive pluripotency (Grabole et al., 2013; Mar-
tello et al., 2013).
Despite the general trend of higher expression of ancillary
factors in 2i/LIF, several previously pluripotency-associated
genes, such as Utf1, Lin28b, and Id genes, are downregulated
in ground state ESCs. This highlights both that these targets
are invoked through distinct pathways and also that their high
expression is not an absolute requirement for pluripotency. A
further question is the degree to which allelic regulation im-
pinges on the stability and state of pluripotency. Indeed, it
was observed that Nanog may be predominantly monoalleically
expressed specifically in serum-cultured ESCs, thereby predis-
posing them to differentiation cues (Miyanari and Torres-Padilla,
2012). Nevertheless, recent reports have suggested Nanog
transcription is biallelic in both 2i/LIF and serum, implying this
mode of regulation is unlikely to underlie significant differences
between pluripotent states/conditions (Faddah et al., 2013; Fil-
ipczyk et al., 2013).
Lineage-Associated Genes
A prominent distinction between ground state ESCs and con-
ventional ESCs is the significant expression of lineage-associ-
ated transcripts in the latter. In particular, genes related to
mesoderm and ectoderm are active in serum conditions but
are near undetectable in 2i/LIF (Marks et al., 2012). To some
extent, this is related to heterogeneity in serum. Nevertheless
the Rex1-positive naive population in serum still exhibits consid-
erable expression of lineage-associated genes. Indeed, the
global transcriptomes between Rex1-positive ESCs in serum
and ESCs in 2i/LIF are clearly distinct (Marks et al., 2012).
Thus, as of yet there is no subpopulation in serum that is tran-
scriptionally equivalent to ground state ESCs. This collectively
suggests that serum ESCs may represent capture of a more
developmentally advanced state linked with onset of some early
differentiation programs, relative to ESCs in 2i/LIF where devel-
opmental gene expression is diminished.
Nonetheless, transcription of certain lineage-associated
genes is detectable in 2i/LIF conditions, particularly germline
and endoderm transcripts. Enhanced germline gene expression
is primarily a consequence of global DNA hypomethylation.
Expression of endoderm genes on the other hand may be
related to the capacity of some ESCs in 2i/LIF to generate
extraembryonic primitive endoderm and/or trophectoderm, in
addition to maintaining naive potential (Morgani et al., 2013).
This is consistent with 2i/LIF conditions supporting capture of
at least some cells in an earlier developmental stage, perhaps
comparable to nascent ICM cells (E3.5) or earlier, rather than
the naive epiblast (E4.5). Significantly, however, expression of
a reporter for the primitive endoderm gene Hex is heteroge-
neous across the population and delineates the subpopulation
most primed toward extraembryonic fate. Thus, while 2i/LIF
conditions establish a relatively homogenous population with
respect to naive pluripotency, there may still be significant
functional and transcriptional heterogeneity related to extraem-
bryonic potential.422 Cell Stem Cell 15, October 2, 2014 ª2014 Elsevier Inc.In contrast, heterogeneity in serum involves dynamic cycling
in and out of various embryonic ‘‘lineage-primed’’ states, and
it has been posited that such metastability is an essential
component of pluripotent identity per se. It is also suggested
that the concomitant expression of multiple lineage specifiers
in serum establishes a balance whereby distinct differentiation
pathways mutually counteract the dominance of each other,
with the upshot being all fates remain accessible and thus
an unrestricted pluripotent state is engendered (Loh and
Lim, 2011). Indeed, forced expression of lineage specifiers
can reprogram somatic cells to pluripotency, supporting the
concept that pluripotency can be established through the equi-
librium of counteracting differentiation forces (Montserrat et al.,
2013; Shu et al., 2013). Nevertheless, the absence of multiline-
age gene expression in 2i/LIF coupled with an apparently uni-
form naive capacity, argues that metastability is not an inherent
property of naive pluripotency but rather may represent a cul-
ture epiphenomenon due to the conflicting stimuli in serum
(Smith, 2013). Importantly, however, the onset of mosaic
expression profiles and heterogeneity may be crucial aspects
that underlie competence for unbiased cell fate commitment
during exit from pluripotency.
Epigenetic Landscapes in Pluripotent States
DNA Modification
DNAmethylation at CpG dinucleotides is a repressive epigenetic
modification typically associated with transcriptional silencing
but also has diverse roles in regulating transposable elements,
splicing, and genome integrity (Smith and Meissner, 2013).
Once established, DNA methylation (5mC) is faithfully propa-
gated through cell divisions and stabilizes restriction of cellular
identity (Bro¨ske et al., 2009; Hemberger et al., 2009; Ng et al.,
2008; Oda et al., 2013). However, during early development,
5mC is dynamically remodeled, leading to a globally hypomethy-
lated state in the ICM (Smallwood et al., 2011; Smith et al., 2012).
The global erasure of 5mC is considered important to remove
epigenetic barriers against the acquisition of pluripotency (Hack-
ett and Surani, 2013). Nevertheless, despite being derived from
the hypomethylated ICM, ESCs in serum accumulate high levels
of global DNA methylation usually associated with primed or
lineage-restricted cells (Meissner et al., 2008).
In contrast, recent studies have shown that ground state ESCs
exhibit a globally hypomethylated DNA methylome, with 5mC
3-fold lower in 2i/LIF-derived ESCs relative to ESCs in serum
(Ficz et al., 2013; Habibi et al., 2013; Leitch et al., 2013). The
levels and distribution of 5mC in 2i/LIF ESCs thus appear
comparable with the derestricted ICM or naive epiblast cells
(E3.5–E4.5), whereas 5mC in serum ESCs is closer to the
hypermethylated state of primed postimplantation epiblast
(E6.5). Moreover, the apparently naive subpopulations in serum
(Rex1/Nanog-positive) still retain elevated global 5mC, under-
scoring that they are not directly equivalent to ground state
ESCs (Ficz et al., 2013; Habibi et al., 2013), albeit the quintile
of ESCs expressing the highest level ofRex1 do appear relatively
hypomethylated (Singer et al., 2014). This may imply that ESCs in
serum dynamically transition into a hypomethylated state at low
frequency. Such dynamic DNAmethylation variation, particularly
at cis-regulatory enhancers, may play a key role in modulating
the functional heterogeneity of serum ESCs, since ablation of
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et al., 2013; Lee et al., 2014). Conversely, stable hypomethylation
in 2i/LIF is probably directly linked with competence for uniform
ground state pluripotency by minimizing epigenetic restrictions
and intercellular variation.
The epigeneticmemory imposed by 5mC is surprisingly plastic
in ESCs as switch from serum to 2i/LIF induces comparatively
rapid hypomethylation, while the reciprocal switch results in
appropriate acquisition of DNA methylation (Leitch et al., 2013;
Shipony et al., 2014). Some loci are resistant to demethylation,
however, such as genomic imprints and IAP elements, which is
consistent with their escape from reprogramming during preim-
plantation development. Mechanistically, resistant loci are en-
riched with H3K9me3, which may act as a platform that blocks
demethylation or that preferentially attracts residual DNAmethyl-
ation activity, perhaps viaUHRF1, which directly bindsH3K9me3
(Bostick et al., 2007; Habibi et al., 2013; Rothbart et al., 2012). On
the other hand, the mechanism that mediates global 5mC
erasure in 2i/LIF may include oxidation of 5mC to 5-hydroxyme-
thylcytosine (5hmC) by TET enzymes since 5hmC is transiently,
but weakly, enriched at some genomic loci during ESC transition
to ground state pluripotency. Indeed, in the absence of Tet1 and
Tet2, both the rate and extent of 5mC erasure is compromised
(Ficz et al., 2013; Hackett et al., 2013). Nevertheless, Tet1/
Tet2/ ESCs can still undergo significant demethylation,
whereas, strikingly, Prdm14/ ESCs fail to become hypomethy-
lated in 2i/LIF. This seems to reflect a key role for PRDM14 in re-
pressing the de novomethylasesDnmt3a andDnmt3b, which are
required for maintenance of 5mC in ESCs (Chen et al., 2003; Gra-
bole et al., 2013; Leitch et al., 2013; Yamaji et al., 2013). Further-
more, PRDM14 also directly targets TET activity (Okashita et al.,
2014), highlighting Prdm14 as a key hub that integrates multiple
synergistic DNA demethylation mechanisms. Thus, DNA hypo-
methylation in ground state ESCs appears to be mediated via
decommissioning the de novo DNA methylation machinery
and, in parallel, through targeted 5hmC conversion.
Interestingly, in contrast to male XY ESCs, which are predom-
inantly studied owing to their higher derivation efficiency, female
XXESCs in serumdo exhibit global DNA hypomethylation. This is
a direct consequence of two active X chromosomes promoting
repression of de novo methyltransferases and pERK activity
(Ooi et al., 2010; Schulz et al., 2014; Zvetkova et al., 2005). The
magnitude of hypomethylation in XX ESCs relative to XY coun-
terparts can vary from 10% to 3-fold depending on the genetic
background and precise culture conditions, such as the pres-
ence of feeders (Hackett et al., 2013; Schulz et al., 2014). Never-
theless, the observation that XX ESCs exhibit significantly
depleted 5mC coupled with blockade of pERK activity suggests
that female ESCs in serum conditions may occupy a pluripotent
state closer to the in vitro ground state. Indeed, DNA hypomethy-
lation per se may serve as a useful marker for benchmarking
pluripotent states and, in particular, for denoting ESCs that
have entered ground state pluripotency.
Histone Modification
The copresence of the activating modification H3K4me3 and
repressive polycomb mark H3K27me3 on chromatin is termed
bivalent. Bivalency is observed in multiple cell types but is a
particularly prominent feature of developmental promoters in
conventional ESCs. The bivalent signature is thought to dampentranscription but maintain a flexible poised state that can be
rapidly reactivated in response to lineage-specifying cues,
albeit evidence is accumulating that bivalency may be function-
ally dispensable (Denissov et al., 2014; Voigt et al., 2013).
Significantly, epigenetic profiling revealed that H3K27me3 is
depleted in ground state ESCs, and consequently the number
of bivalent domains is dramatically reduced. The reduction of
H3K27me3 in 2i/LIF may be a direct effect of ERK inhibition,
since ERK is necessary for EED activity at target promoters
(Tee et al., 2014). Nevertheless, the developmental genes that
lose H3K27me3 in 2i/LIF are generally not derepressed, implying
that alternative mechanisms constrain their expression (Marks
et al., 2012). Notably, polycomb is dispensable for ESC self-
renewal, as is DNA methylation (Leeb et al., 2010; Tsumura
et al., 2006), but their absence abrogates differentiation, indi-
cating that these repressive epigenetic systems primarily func-
tion in the initiation andmaintenance of cell fate restriction rather
than pluripotent identity per se.
We await detailed reports on the relative abundance and distri-
butions of other chromatinmodifications between various plurip-
otent states. One observation however is that pluripotent cells
in 2i/LIF may exhibit a global reduction of the repressive marks
H3K9me2 and H3K9me3 (Leitch et al., 2013). There is also a
reported concomitant increase in H3K4me3, while PADI4,
which citrulinates linker histone H1 to decompact chromatin, is
also upregulated in ground state conditions (Christophorou
et al., 2014). Thus, multiple repressive modifications (5mC,
H3K27me3, H3K9me2, H3K9me3) are apparently depleted, or
at least redistributed, in 2i/LIF conditions, while several epige-
netic mechanisms linked with decondensed chromatin are
active. This observation is consistent with ground state cells
acquiring a derestricted epigenetic state that is conducive to
the onset of all developmental programs, upon appropriate cues.
Transcriptional Pausing
One potential consequence of a general reduction of repressive
epigenetic modifications is precocious transcription. Neverthe-
less despite previous suggestions (Efroni et al., 2008), neither
ESCs cultured in 2i/LIF nor in serum appear to exhibit global
transcriptional hyperactivity, suggesting that alternative mecha-
nisms may be in place to regulate transcription (Marks et al.,
2012). One possibility is that RNA polymerase II (Pol II) pausing
at promoter proximal sites has a prominent role. Such a regula-
tory mechanism may be important at lineage-specific genes in
early embryonic cells and, indeed, promoter proximal Pol II
pausing is prevalent in ESCs in serum. This may be mediated
in part by ERK1/2 activity, which directly phosphorylates the
CTD at developmental genes thereby promoting Pol II pausing
(Tee et al., 2014). Strikingly, however, ESCs grown in 2i/LIF
exhibit a significantly greater extent of promoter proximal
pausing relative to ESCs in serum, and this effect is particularly
evident at developmental genes, among others (Marks et al.,
2012). Pol II pausing may therefore be a crucial regulatory mech-
anism associated with ground state pluripotency. However, as
ERK activity is blocked in 2i/LIF conditions, it is unclear what
mechanisms direct such elevated transcriptional pausing.
The Extended Spectrum of Pluripotent States
The emerging theme from multiple studies is that pluripotency,
as a functional property, is not restricted to a specific underlyingCell Stem Cell 15, October 2, 2014 ª2014 Elsevier Inc. 423
Figure 4. Embryonic Origin and Spectrum of Pluripotent Stem Cell
States
The pluripotent cells of a blastocyst between E3.5 and E4.5 can give rise to
functionally naive ESCs (blue). Between E5.5 and E8.0 postimplantation
epiblast can establish EpiSCs (orange), which occupy a primed pluripotent
state. Additionally, primordial germ cells (PGCs), which are the founders of the
germline lineage, can give rise to naive EGCs (green), which are highly com-
parable to ESCs. Depending on the culture/derivation conditions these
pluripotent stem cells occupy discrete molecular states that can be broadly
classed as naive or primed. The most optimized state of naive pluripotency,
which closely recapitulates the naive epiblast cells of the blastocyst, is termed
ground state. An interchangeable spectrumof pluripotent statesmay arise that
ranges from ground state to primed pluripotency. The state of pluripotency
adopted in vitro is primarily dictated by the combination extrinsic signals in the
culture environment rather than the developmental source of the pluripotent
cells. CH, Chiron; PD, PD03.
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appears to be a surprisingly broad bandwidth ofmolecular states
that can confer pluripotent properties. This plasticity/flexibility
effectively results in a spectrum of pluripotency, upon which
pluripotent states are progressively more restricted, or at least
altered, but nonetheless still exhibit some defining features of
pluripotency (Figure 4). At one end of the continuum is the
ground state, which perhaps represents the state of broadest
and most unrestricted developmental potential. Indeed, a frac-
tion of ground state ESCs in 2i/LIFmay be functionally totipotent,
capable of contribution to embryonic and extraembryonic line-
ages (Morgani et al., 2013). At the other end of the spectrum is
the so-called ‘‘primed’’ pluripotent state, as exemplified by
EpiSCs.424 Cell Stem Cell 15, October 2, 2014 ª2014 Elsevier Inc.EpiSCs are established frommouse postimplantation epiblast
and beyond (E5.5–E8.0) and require bFGF and Activin A sig-
naling to maintain self-renewal (Brons et al., 2007; Tesar et al.,
2007). EpiSCs exhibit pluripotent features such as the capacity
to undergo multilineage differentiation in vitro and efficiently
form teratomas in vivo, while they also express the core pluripo-
tency factors Oct4 and Sox2. However, Oct4 expression in
EpiSCs is primarily driven by its proximal enhancer, as opposed
to the distal enhancer that is active in naive ESCs, and this
distinction is often used as a proxy to distinguish between
primed and naive pluripotent states. Transcriptionally, EpiSCs
exhibit reduced/absent expression of many ancillary pluripo-
tency factors, including Klf4, Klf5, Prdm14, Rex1, and Esrrb,
which is in part due to attenuated Nanog expression (Festuccia
et al., 2012). Moreover, EpiSCs accumulate epigenetic barriers
incompatible with a naive state such as female X chromosome
inactivation and promoter DNA methylation at pluripotency
genes. Consequently, primed EpiSCs contribute poorly or not
at all to blastocyst chimeras and are thus functionally distinct
from naive ESCs. Instead, EpiSCs appear to functionally
resemble the anterior primitive streak (Kojima et al., 2014), albeit
there is considerable heterogeneity at the population level and
forced expression of E-Cadherin can restore naive potential
(Ohtsuka et al., 2012). Notably, an alternative model of the
primed state known as epiblast-like cells (EpiLCs) has recently
been developed, and although EpiLCs more closely parallel the
postimplantation epiblast (E5.5–E6.5) than do EpiSCs, they do
not self-renew (Hayashi et al., 2011). Nonetheless, the transient
EpiLC population is a highly useful system to model pluripotent
state transitions.
Between the states characterized by ground state ESCs and
lineage-primed EpiSCs, theremay be a continuumof self-renew-
ing pluripotent states with distinct functional and transcriptional
signatures and biases. These appear to be primarily a conse-
quence of extrinsic influences modulated by culture conditions,
with serum conditions, for example, perhaps being intermediate
on the spectrum. Like 2i/LIF culture, such conventional serum
conditions promote cells with naive potential (germline compe-
tent), which are at least Rex1 positive. However, as judged by
several criteria, the Rex1-positive ESCs in serum appear more
developmentally advanced than ground state ESCs in 2i/LIF
and thus occupy a discretemolecular state of naive pluripotency.
Serum conditions additionally support cells with apparent
‘‘primed’’ properties (Oct4 positive/Rex1 negative). This subpop-
ulation is however functionally distinct from primed EpiSCs as
inferred from the observation that EpiSCs, but not ESCs, can
readily contribute to all germ layerswhen engrafted onto cultured
postimplantation embryos (Huang et al., 2012). Collectively, this
suggests that the pluripotent state(s) that arise in serum condi-
tions occupy positions along the spectrumbetween ground state
and primed cells. Another so-called ‘‘2C’’ state is also reported to
exist in serum, which apparently closely parallels two-cell em-
bryos at the transcriptional level (Macfarlan et al., 2012). Further
pluripotent ‘‘states’’ may be generated according to precise cul-
ture conditions that intercalate between ground state, serum,
and primed states. For example, various combinations and/or
concentrations of PD03, CHIRON, BMP4, and LIF could
engender distinct pluripotent cells, with different properties to
bona fide ground state ESCs in 2i/LIF (or 2i) (Figure 4) (Chen
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profound effects. The addition of vitamin C or knockout serum
replacement (KSR) to conventional culture conditions, for
example, promotes TET catalytic activity, leading to global
DNA hypomethylation and an altered transcriptional profile
(Blaschke et al., 2013). The presence or absence of feeders
also impinges on the precise molecular signature of ESCs.
Thus, a range of pluripotent states exist that are, in general, a
direct response to culture conditions. It remains to be deter-
mined precisely what the functional differences are between
such states and whether they might correspond to successive
pluripotent phases during ontogeny. Notably, however, most no-
des along the pluripotent spectrum in vitro are reversible just by
interchanging culture parameters, albeit EpiSCs are somewhat
restricted (Bao et al., 2009). Indeed, pluripotent stem cells from
distinct developmental origins also assume the state dictated
by conditions rather than the embryonic source. Embryonic
germ cells (EGCs) derived from PGCs, for example, are almost
indistinguishable from ICM-derived ESCs, when both are in the
same media (2i/LIF or serum) (Leitch et al., 2013). Moreover,
the ICM forms self-renewing EpiSCs, rather than ESCs, when
derived in appropriate media, while postimplantation epiblast
can form ESCs rather than EpiSCs in serum/LIF (Bao et al.,
2009; Najm et al., 2011). This collectively implies that up to a
threshold level of progressive restriction, pluripotency is plastic
and can revert throughmultiple molecular states through altering
culture parameters, which are therefore the dominant influence
over which pluripotent state emerges (McEwen et al., 2013). It
is therefore crucially important to consider the precise culture
environment when inferring absolute conclusions related to
pluripotent identity.
Toward Naive Human ESCs
The matter of pluripotent ‘‘state’’ is particularly relevant when
considering human ESCs (hESCs), which have been considered
to occupy a phase of pluripotency with more similarity to themu-
rine primed rather than naive state and thus a relatively advanced
position on the spectrum (De Los Angeles et al., 2012). This
classification of hESCs as ‘‘primed’’ is based on several lines
of evidence including expression of Oct4 driven by its proximal
enhancer, relatively high primed/lineage-associated gene
expression (such as Fgf5 and Lefty1), global DNA hypermethyla-
tion, morphological similarity to EpiSCs, and reliance on FGF/
Activin for self-renewal. Moreover, hESCs are not LIF respon-
sive, while conventional 2i conditions elicit neural differentiation,
implying that unlike mouse ESCs, 2i does not select against the
expansion of differentiated cell types in hESC cultures (Hirano
et al., 2012; Theunissen et al., 2014). As such, it has become a
question of great interest whether hESCs, and by extension
human iPSCs, can be coaxed into the naive state. This may
enhance their developmental potential, facilitate genetic/experi-
mental manipulation, and potentially enable purer populations of
differentiated cells to be generated, all of which would have im-
plications for development of disease models and regenerative
therapies.
Several studies have reported that after transgenic interven-
tions, hESCs/iPSCs with naive properties can be derived and
maintained (Buecker et al., 2010; Hanna et al., 2010; Wang
et al., 2011). However, the requirement for continued geneticmanipulation limits their clinical utility and it is desirable to
identify culture conditions that directly support human naive plu-
ripotency independently of transgenes. A precedent for this
possibility is that primed EpiSCs revert to a naive state at low
frequency when switched to mouse naive culture conditions
(Bao et al., 2009; Gillich et al., 2012), albeit primed hESCs do
not respond equivalently.
To address this, human-specific conditions for putative naive
states have recently been developed. For example, hESCs
cultured in basal media containing FGF and TGF supplemented
with 2i, LIF, and Dorsomorphin (AMP kinase and BMP inhibitor)
upregulate multiple naive markers including NANOG, KLF4,
and TBX3 (Chan et al., 2013). Alternative culture parameters
include 2i, FGF, and KSR either supplemented with LIF and
ROCK inhibitor (Valamehr et al., 2014) or without (Ware et al.,
2014). Indeed, monkey iPSCs are also reported to acquire
several naive traits using variations of the 2i/LIF/FGF condition
(Fang et al., 2014). Another study using a panel of six inhibitors
including 2i/LIF reported hESCs with many apparent naive
features and contribution to interspecies chimeras, albeit it is un-
clear whether this can be used as a robust test for naive plurip-
otency (Gafni et al., 2013). Finally, using a targeted reporter for
OCT4 expression from its naive-specific distal enhancer, a
comprehensive screen identified an alternative combination of
six inhibitors (2i, ROCKi, BRAFi, SRCi, and JNKi) supplemented
with LIF and Activin. Under these conditions, hESCs appear to
exhibit a more compelling upregulation of naive markers, as
judged by equivalence with mouse ESCs, but lack other naive
features such as two active X chromosomes in female cells
(Theunissen et al., 2014).
A significant issue toward establishment of naive hESCs is
that, at present, there is no universal defining test for naive plu-
ripotency in a human system, unlikemurine ESCswhere chimera
contribution to blastocysts is the benchmark. Assigning naive
status to hESCs is therefore generally based on a molecular
rather than a functional basis. One key parameter to consider
is similarity to the global gene expression profile of human preim-
planation epiblast cells (Yan et al., 2013), which represent the
human ground state. Additionally, global DNA hypomethylation
(<40%) appears to be a fundamental feature of naive pluripo-
tency both in vitro and during preimplantation development in
human and mouse (Guo et al., 2014; Smith et al., 2014; Wang
et al., 2014) and should be used as a critical benchmark for
bona fide ground state status in hESCs. Given this, the recent
report that hESCs exhibit significant global DNA hypomethyla-
tion and clustermore closely with in vivo epiblast at the transcrip-
tional level is of great interest (Takashima et al., 2014). Here,
transient expression of NANOG and KLF2 followed by switch
to 2i/LIF (with titrated CHIRON) in conjunction of PKC inhibitor
enabled expansion of ‘‘reset’’ hESCs that show all tested molec-
ular features of ground state pluripotency, including two active X
chromosomes and diminished lineage-associated expression.
Functionally, these cells rely on TCFP2l1 analogous to mouse
ESCs in 2i and can contribute to the ICM in early mouse em-
bryos, unlike conventional hESCs. While there is an initial
requirement for forced transgene expression, this can also be
achieved without genetic intervention implying that human
pluripotent stem cells have the intrinsic capacity to occupy a
state closely comparable to mouse ground state ESCs.Cell Stem Cell 15, October 2, 2014 ª2014 Elsevier Inc. 425
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between hESCs and ground state epiblast cells in vivo. As
such, important steps have been taken toward generating
bona fide naive human stem cells and have led to multiple novel
pluripotent ‘‘states’’ being established. Similarly, to the pluripo-
tent spectrum in mice, these distinct states of human pluripo-
tency probably have discrete features and functional benefits
for future research and may potentially reflect successive plurip-
otent phases in vivo.
Perspective
The capture of naive pluripotency has enabled unparalleled in-
vestigations into development and disease. Studies are also un-
covering the extrinsic and intrinsic regulators of pluripotency per
se, revealing a broad bandwidth of influences that feed into the
balance between maintenance or exit from self-renewal. One
consequence of this is that a spectrum of self-renewing pluripo-
tent ‘‘states’’ emerges depending on extrinsic cues in the culture
environment. Ongoing refinements to such parameters will help
to shed more light on the underlying mechanisms of pluripo-
tency, and importantly, how this property can be further ex-
ploited for research and biomedical purposes. The insights
gained from murine models are now being applied to human
ESCs and iPSCs, which hold great promise for therapeutic appli-
cations.
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